What is the price-to-earnings ratio of Saniona?
The price-earnings ratio of Saniona is currently 0.4.
Saniona P/S 2024
Saniona P/S
0.4
Ticker
SANION.ST
ISIN
SE0005794617
WKN
A110VV
As of Jul 10, 2024, Saniona's P/S ratio stood at 0.4, a -98.69% change from the 30.58 P/S ratio recorded in the previous year.
The Saniona P/S history
Saniona Aktienanalyse
What does Saniona do?
Saniona AB is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutics for rare diseases. The company was previously known as Saniona AB (until 2014) and NeuroNova AB (until 2012). It was founded in Copenhagen, Denmark, in 2006 and quickly expanded to other countries. In 2013, the company opened an office in Boston, USA, to expand its activities in North America. Saniona AB is listed on the NASDAQ Stockholm and currently has over 60 employees worldwide. The company's business model revolves around discovering and developing drugs for rare diseases that have little to no existing therapies. They use a proprietary technology platform called Ion Channels and G Protein-Coupled Receptors (GPCRs) to identify novel compounds that could meet these urgent medical needs. Saniona AB aims to develop successful medications and sell them either through partnerships or their own marketing activities. The company operates in various areas, including rare diseases, the nervous system (developing drugs for movement disorders and psychiatric disorders), and diabetes and obesity. Saniona AB has several drug candidates in its pipeline targeting different therapeutic applications, with some in various stages of clinical development. One of its key products is Tesomet, a candidate for the treatment of Prader-Willi syndrome and hypothalamic-pituitary hormone disorders, which is currently in Phase 3 of clinical development. Another important candidate is AN788, being investigated in Phase 2 clinical studies for the treatment of idiopathic pulmonary fibrosis. In conclusion, Saniona AB is an emerging biopharmaceutical company developing innovative drugs for rare diseases. With a specialization in researching rare diseases with significant medical needs and unmet treatment options, the company utilizes a proprietary technology platform to identify new compounds that aim to fulfill these medical needs. With multiple drug candidates in development and a strong partnership strategy, Saniona is well-positioned to maximize the potential of its innovative therapies and benefit patients in need. Saniona ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Saniona's P/S Ratio
Saniona's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Saniona's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Saniona's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Saniona’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Saniona stock
How has the price-earnings ratio of Saniona changed compared to last year?
The price-to-earnings ratio of Saniona has increased by -98.69% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Saniona high compared to other companies?
Yes, the price-to-earnings ratio of Saniona is high compared to other companies.
How does an increase in the price-earnings ratio of Saniona affect the company?
An increase in the price-earnings ratio of Saniona would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Saniona affect the company?
A decrease in the price-earnings ratio of Saniona would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Saniona?
Some factors that influence the price-earnings ratio of Saniona are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Saniona pay?
Over the past 12 months, Saniona paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Saniona is expected to pay a dividend of 0 SEK.
What is the dividend yield of Saniona?
The current dividend yield of Saniona is .
When does Saniona pay dividends?
Saniona pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Saniona?
Saniona paid dividends every year for the past 0 years.
What is the dividend of Saniona?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Saniona located?
Saniona is assigned to the 'Health' sector.
Wann musste ich die Aktien von Saniona kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Saniona from 7/10/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.
When did Saniona pay the last dividend?
The last dividend was paid out on 7/10/2024.
What was the dividend of Saniona in the year 2023?
In the year 2023, Saniona distributed 0 SEK as dividends.
In which currency does Saniona pay out the dividend?
The dividends of Saniona are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Saniona
Our stock analysis for Saniona Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Saniona Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
